{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T21:54:34Z","timestamp":1697406874216},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1006\/mpat.2000.0419","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T19:46:30Z","timestamp":1032378390000},"page":"139-148","source":"Crossref","is-referenced-by-count":17,"title":["Murine monoclonal antibodies to PorA of Neisseria meningitidis show reduced protective activity in vivo against B:15:P1.7,16 subtype variants in an infant rat infection model"],"prefix":"10.1006","volume":"30","author":[{"given":"Maija","family":"Toropainen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena","family":"Saarinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"van der Ley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betsy","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"K\u00e4yhty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/mpat.2000.0419_RF1","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"key":"10.1006\/mpat.2000.0419_RF2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"key":"10.1006\/mpat.2000.0419_RF3","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","article-title":"Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil","volume":"340","author":"de Moraes","year":"1992","journal-title":"Lancet"},{"key":"10.1006\/mpat.2000.0419_RF4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"key":"10.1006\/mpat.2000.0419_RF5","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/IAI.63.12.4642-4652.1995","article-title":"Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine","volume":"63","author":"Rosenqvist","year":"1995","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.2000.0419_RF6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/IAI.51.2.571-578.1986","article-title":"Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting","volume":"51","author":"Wedege","year":"1986","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.2000.0419_RF7","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/IAI.64.7.2745-2751.1996","article-title":"Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine","volume":"64","author":"van der Voort","year":"1996","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.2000.0419_RF8","first-page":"147","article-title":"Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey","volume":"14","author":"H\u00f8iby","year":"1991","journal-title":"NIPH Ann"},{"key":"10.1006\/mpat.2000.0419_RF9","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"key":"10.1006\/mpat.2000.0419_RF10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0882-4010(88)90045-9","article-title":"Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA","volume":"4","author":"Abdillahi","year":"1988","journal-title":"Microb Pathog"},{"key":"10.1006\/mpat.2000.0419_RF11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/clinids\/7.4.504","article-title":"Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes","volume":"7","author":"Frasch","year":"1985","journal-title":"Rev Infect Dis"},{"key":"10.1006\/mpat.2000.0419_RF12","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1128\/IAI.66.10.4755-4761.1998","article-title":"Specificity of bactericidal antibody response to serogroup B meningococcal strains in brazilian children after immunization with an outer membrane vaccine","volume":"66","author":"Milagres","year":"1998","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.2000.0419_RF13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2958.1989.tb01802.x","article-title":"The class 1 outer membrane protein of Neisseria meningitidis: gene sequence and structural and immunological similarities to gonococcal porins","volume":"3","author":"Barlow","year":"1989","journal-title":"Mol Microbiol"},{"key":"10.1006\/mpat.2000.0419_RF14","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1084\/jem.171.6.1871","article-title":"Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity","volume":"171","author":"McGuinness","year":"1990","journal-title":"J Exp Med"},{"key":"10.1006\/mpat.2000.0419_RF15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2958.1991.tb00743.x","article-title":"Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidis","volume":"5","author":"Maiden","year":"1991","journal-title":"Mol Microbiol"},{"key":"10.1006\/mpat.2000.0419_RF16","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1128\/IAI.59.9.2963-2971.1991","article-title":"Topology of outer membrane porins in pathogenic Neisseria spp","volume":"59","author":"van der Ley","year":"1991","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.2000.0419_RF17","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1128\/IAI.67.5.2406-2413.1999","article-title":"Structural and evolutionary interference from molecular variation in Neisseria porins","volume":"67","author":"Derrick","year":"1999","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.2000.0419_RF18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/jcm.9.2.186-188.1979","article-title":"Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978","volume":"9","author":"Holten","year":"1979","journal-title":"J Clin Microbiol"},{"key":"10.1006\/mpat.2000.0419_RF19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1139\/w97-121","article-title":"Sequencing of porA from clinical isolates of Neisseria meningitidis defines a subtyping scheme and its genetic regulation","volume":"44","author":"Arhin","year":"1998","journal-title":"Can J Microbiol"},{"key":"10.1006\/mpat.2000.0419_RF20","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/CDLI.3.4.444-450.1996","article-title":"Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design","volume":"3","author":"Feavers","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1006\/mpat.2000.0419_RF21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2958.1994.tb01014.x","article-title":"The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation","volume":"12","author":"Suker","year":"1994","journal-title":"Mol Microbiol"},{"key":"10.1006\/mpat.2000.0419_RF22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2958.1993.tb01141.x","article-title":"Class 1 outer membrane protein of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology","volume":"7","author":"McGuinness","year":"1993","journal-title":"Mol Microbiol"},{"key":"10.1006\/mpat.2000.0419_RF23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0882-4010(87)90059-3","article-title":"Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development","volume":"3","author":"Saukkonen","year":"1987","journal-title":"Microb Pathog"},{"key":"10.1006\/mpat.2000.0419_RF24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1099\/00222615-38-1-23","article-title":"Expression of an inaccessible P1.7 subtype epitope on meningococcal class 1 proteins","volume":"38","author":"Wedege","year":"1993","journal-title":"J Med Microbiol"},{"key":"10.1006\/mpat.2000.0419_RF25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1099\/13500872-142-1-63","article-title":"Monoclonal antibody recognition of members of the meningococcal P1.10 variable region family: implications for serological typing and vaccine design","volume":"142","author":"Suker","year":"1996","journal-title":"Microbiology"},{"key":"10.1006\/mpat.2000.0419_RF26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/mpat.1993.1070","article-title":"A new variant of serosubtype P1.16 in Neisseria meningitidis from Norway, associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccine","volume":"15","author":"Rosenqvist","year":"1993","journal-title":"Microb Pathog"},{"key":"10.1006\/mpat.2000.0419_RF27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0140-6736(91)91297-8","article-title":"Point mutation in meningococcal por A gene associated with increased endemic disease","volume":"337","author":"McGuinness","year":"1991","journal-title":"Lancet"},{"key":"10.1006\/mpat.2000.0419_RF28","first-page":"2","article-title":"Meningococcal outbreak in Southern Finland","volume":"June","author":"Ristola","year":"1995","journal-title":"Eurosurveillance"},{"key":"10.1006\/mpat.2000.0419_RF29","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/S0264-410X(99)00049-3","article-title":"The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci","volume":"17","author":"Toropainen","year":"1999","journal-title":"Vaccine"},{"key":"10.1006\/mpat.2000.0419_RF30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2958.1992.tb01493.x","article-title":"Role of horizontal genetic exchange in the antigenic variation of the class 1 outer membrane protein of Neisseria meningitidis","volume":"6","author":"Feavers","year":"1992","journal-title":"Mol Microbiol"},{"key":"10.1006\/mpat.2000.0419_RF31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1574-6968.1993.tb06457.x","article-title":"Population genetics of a transformable bacterium: the influence of horizontal genetic exchange on the biology ofNeisseria meningitidis","volume":"112","author":"Maiden","year":"1993","journal-title":"FEMS Microbiol Lett"},{"key":"10.1006\/mpat.2000.0419_RF32","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/S0264-410X(00)00047-5","article-title":"Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine","volume":"18","author":"Martin","year":"2000","journal-title":"Vaccine"},{"key":"10.1006\/mpat.2000.0419_RF33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1006\/abio.1997.2064","article-title":"On the interaction between a bactericidal antibody and a PorA epitope of Neisseria meningitidis in outer membrane vesicles: a competitive fluorescence polarization immunoassay","volume":"247","author":"van den Elsen","year":"1997","journal-title":"Anal Biochem"},{"key":"10.1006\/mpat.2000.0419_RF34","doi-asserted-by":"crossref","first-page":"12583","DOI":"10.1021\/bi9700431","article-title":"Thermodynamic analysis of the interaction between a bactericidal antibody and a PorA epitope of Neisseria meningitidis","volume":"36","author":"van den Elsen","year":"1997","journal-title":"Biochemistry"},{"key":"10.1006\/mpat.2000.0419_RF35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1097-0134(199709)29:1<113::AID-PROT9>3.0.CO;2-G","article-title":"Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: crystal structure of a Fab fragment in complex with a fluorescein-conjugated peptide","volume":"29","author":"van den Elsen","year":"1997","journal-title":"Proteins"},{"key":"10.1006\/mpat.2000.0419_RF36","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/0264-410X(95)00101-6","article-title":"The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis","volume":"13","author":"Idanpaan-Heikkila","year":"1995","journal-title":"Vaccine"},{"key":"10.1006\/mpat.2000.0419_RF37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0882-4010(88)90070-8","article-title":"Experimental meningococcal meningitis in the infant rat","volume":"4","author":"Saukkonen","year":"1988","journal-title":"Microb Pathog"},{"key":"10.1006\/mpat.2000.0419_RF38","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/CDLI.1.6.729-736.1994","article-title":"Development, characterization, and biological properties of meningococcal immunotype L3,7,(8),9-specific monoclonal antibodies","volume":"1","author":"Verheul","year":"1994","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1006\/mpat.2000.0419_RF39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0003-2697(91)90488-F","article-title":"Preparation and application of a fluorescein-labeled peptide for determining the affinity constant of a monoclonal antibody-hapten complex by fluorescence polarization","volume":"196","author":"Jiskoot","year":"1991","journal-title":"Anal Biochem"},{"key":"10.1006\/mpat.2000.0419_RF40","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1073\/pnas.82.4.1194","article-title":"NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci","volume":"82","author":"Frosch","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/mpat.2000.0419_RF41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1574-6968.1987.tb02626.x","article-title":"Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies","volume":"48","author":"Abdillahi","year":"1987","journal-title":"FEMS Microbiol Lett"},{"key":"10.1006\/mpat.2000.0419_RF42","first-page":"2483","article-title":"Variation in the expression of pili and outer membrane protein by Neisseria meningitidis during the course of meningococcal infection","volume":"132","author":"Tinsley","year":"1986","journal-title":"J Gen Microbiol"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401000904194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401000904194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T19:49:59Z","timestamp":1680551399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401000904194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["S0882401000904194"],"URL":"https:\/\/doi.org\/10.1006\/mpat.2000.0419","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}